Isobolographic analysis of analgesic interactions of silymarin with ketamine in mice by NASER, A.S. et al.
   
   




  Isobolographic analysis of analgesic interactions
of silymarin with ketamine in mice




University of Mosul, Mosul,
Iraq









  Copyright © 2020 A.S. NASER, Y. ALBADRANY,
K.A. SHAABAN 
   
  
   
To cite this article:
NASER, A.S., ALBADRANY, Y., & SHAABAN, K.A. (2020). Isobolographic analysis of analgesic interactions of silymarin
with ketamine in mice. Journal of the Hellenic Veterinary Medical Society, 71(2), 2171-2178.
doi:https://doi.org/10.12681/jhvms.23653
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 23/08/2021 03:59:16 |
Research article
Ερευνητικό άρθρο
J HELLENIC VET MED SOC 2020, 71(2): 2171-2178
ΠΕΚΕ 2020, 71(2): 2171-2178
ABSTRACT: The present study was undertaken to explore the analgesic effect of silymarin and ketamine alone or 
in combination in mice. Analgesia was measured by using a hot plate and the writhing test. The up-and-down method 
was used to determine the median effective analgesic dosages (ED50s) of silymarin and ketamine administered intraper-
itoneally (ip) either alone or together. The ED50s of both drugs were analyzed isobolographically to determine the type 
of pharmacological interaction between them. The analgesic ED50s for silymarin and ketamine in mice were 57.22 and 
1.96 mg/kg, ip, respectively. Concomitant administration of the silymarin and ketamine at fixed ration (0.5:0.5) of their 
individual ED50s was 38.4 mg/kg and 1.28 mg/kg, ip, respectively. Silymarin and ketamine at fixed ration (1:1) of their 
individual ED50s were 47.54 mg/kg and 1.58 mg/kg, ip, respectively . Depending on the isobolographic analysis and 
calculating Y value, the type of pharmacological interaction between silymarin and ketamine at a ratio of 0.5:0.5 and 
1:1 of their analgesic ED50 values of each drug , was antagonistic .In the writhing test the concomitant administration of 
silymarin and ketamine at 120mg/kg and 4mg/kg , ip, respectively reduce significantly the numbers of writhing in com-
pare with silymarin120 mg/kg,ip and ketamine 4mg/kg, ip separately. The results suggest that the co-administration of 
silymarin and ketamine was ineffective to reduce the central pain while the concomitant administration of silymarin 
and ketamine was effective to reduce the visceral pain. 
Keywords: silymarin, ketamine, analgesia, isobolographic, hotplate, mice.
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INTRODUCTION 
Ketamine is an anesthetic and pain killeragen-tused in human and animals for anesthesia which 
characterized by hypnosis and good analgesia with 
muscle rigidity(Carter & Story, 2013; Persson, 2013; 
Tawfic, 2013). Ketamine inhibits the polysynaptic ac-
tions of the excitatory neurotransmitter acetylcholine 
(Ach) and glutamate in the spinal cord and block the 
N-methyl-D-aspartate receptor complex (Hsu, 2013). 
Ketamine used in human(Aiello & Mays, 1998)and 
veterinary clinic (Rang, Dale, Ritter, & Moore, 2003)
as a general anesthetic agent usually in combination 
with sedatives, tranquilizers and analgesics. Ket-
amine combinations with sedatives, tranquilizers and 
analgesics are also used as balanced anesthetics and 
restraining agents in wild animals(Carter & Story, 
2013; Coetzee, 2013; Short, 1992). Further, ketamine 
have anticonvulsant activity in mice (Tricklebank, 
Singh, Oles, Preston, & Iversen, 1989) and chicks 
(Reder, Trapp, & Troutman, 1980)
Silymarin (milk thistle), a medical herb belong-
ing to the Asteraceae family(Ottai& Abdel-Moniem, 
2006), is home Southern Europe, Southern Russia, 
Asia Minor and Northern Africa (Abenavoli, Capas-
so, Milic, & Capasso, 2010).Silymarin is mixture of 
silibinin A and B (silybin A and B), silydianin and 
silychristin. Other flavonolignans include isosilybin 
A and B, isosilychristin and taxifolin(Ottai & Ab-
del-Moniem, 2006; Stolf, Cardoso, & Acco, 2017).
Silymarin was used for the management of nu-
merous liver disorders including cirrhosis, hepatitis 
(Herz, Heywood, Harborne, & Turner, 1977; Luper, 
1998) Except hepatoprotective effects, it has cardio-
protective, neuroprotective, cytoprotective, anti-in-
flammatory , analgesic and anti-carcinogenic effects 
(Manna, Mukhopadhyay, Van, & Aggarwal, 1999; 
Naser & Amin, 2019; Škottová et al., 2003)A useful 
practice is a combination of two drugs with the same 
therapeutic effect where in each agent is administered 
to obtain additive, synergistic or antagonism inter-
action in a fixed ratio. If the combination resulted in 
addition or synergism, the doses employed by each 
drug are reduced, then the side effects are decline; this 
type of study is calledisobolographic analysis (Raffa, 
2001). 
The purpose of the presentstudy was to explore 
the analgesic effect of silymarin and ketamine com-
bination in mice. The models of pain induction used 
were the hot plateand chemical-induced writhing, 
which are predictive of acute pain responses with in-
volvement of central and peripheral systems, respec-
tively(Acharya et al., 2011; Barrot, 2012; de Campos 
Buzzi et al., 2010; Jain, Kulkarni, & Singh, 2001).
 MATERIALS AND METHODS
46 Male and female Swiss albino mice weighing 
28–33 g were housed at a temperature of 20 ± 2°C 
and 10/14 h light/dark cycle, with water and food ad 
libitum. All experiments complied with institutional 
regulations addressing animal use, and the mice re-
ceived suitable attention and humane care. The Scien-
tific Committee of the physiology, biochemistry and 
pharmacology of the College of Veterinary Medicine 
at the University of Mosul has reviewed and approved 
the protocol of this study. The required doses of The 
commercial powder of silymarin (175mg, 21ST Cen-
tury HealthCare, Inc.) was dissolved in propylene 
glycol(Sigma chemical CO. 99%) . Ketamine (10 % 
injectable solution, DOPHARMA Netherland.) was 
further diluted in saline solution (Pharmaceutical 
Solution Industry, Saudi Arabia) to obtain the desired 
concentrations of the drug. The volume of administra-
tion of each drug was at 5 ml/kg body weight given 
intraperitoneally (ip). Two experimenters simultane-
ously observed the responses of the mice during the 
experiments which were conducted between 9–12 
a.m. 
Experiments 
The up-and-down method (Dixon, 1980)was used 
to determine the median effective analgesic dosag-
es (ED50s) of silymarin and ketamine (administered 
either alone, or concomitantly – silymarin followed 
immediately with ketamine) in mice. The initial dose 
of silymarin was at 100 mg/kg, ipwhereas that of ket-
amine was at 2 mg/kg, ip. In the combination exper-
iment, the initial dosages of silymarin and ketamine 
were 30 and 1 mg/kg, ip, respectively (50:50 of their 
individual ED50 values) and the initial dosages of sily-
marin and ketamine were 60 and 2 mg/kg, ip, respec-
tively (1:1 of their individual ED50 values) . We based 
our choices for silymarin and ketamine dosages on 
preliminary experiments in mice, as well as on previ-
ous studies (G. Jadhav & Upasani, 2009; Mohammad, 
Al-Baggou, & Naser, 2012; Sabiu, Sunmonu, Ajani, 
& Ajiboye, 2015; Vahdati Hassani et al., 2015) . An-
algesia was measured by the thermal method using a 
hot plate (Panlab, S.I.U., Cornella, Spain) held at a 
temperature of 56°C. Mice were individually placed 
on the hot plate 15 min after the drug administration 
and the latency time to the first hind paw removal/ 
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licking and/or jumping response was measured (Bar-
rot, 2012; Le Bars, Gozariu, & Cadden, 2001)The 
cutoff point latency for the induction of analgesia was 
equal to or more than 6 s (i.e., positive analgesic re-
sponse), and the maximum time allowed for the ani-
mal to stay on the hot plate was 20 s to prevent tissue 
damage .. The ED50s of both drugs were subjected to 
isobolographic analysis to determine the type of inter-
action involved in the administration of silymarin and 
ketamine concomitantly (Gonzalez, Zegpi, Noriega, 
Prieto, & Miranda, 2011; Mohammad, Al-Zubaidy, & 
Alias, 2007; Tallarida, 1992)A straight line was drawn 
for the isobolographic analysis between isoeffective 
analgesic doses (ED50) of silymarin and ketamine 
given to the mice either alone or in combination. The 
ED50 points of silymarin and ketamine given alone are 
represented on the x- and y-axes, respectively. The 
straight diagonal line indicates the line of additivity 
(zero interaction) at the ED50 values, and the location 
of the combination points on the left (below) and right 
(above) sides of the additive line indicates synergistic 
and antagonistic interactions, respectively (Gonzalez 
et al., 2011; Mohammad et al., 2007; Tallarida, 1992)
The interaction index was calculated by the equation 
da/Da + db/Db(Tallarida, 1992)Da and Db are the in-
dividual ED50s of silymarin and ketamine for the in-
duction of analgesia, respectively, whereas da and db 
are their combined ED50s for causing analgesia. An in-
teraction index of 1 means additively (no interaction), 
<1 synergism and > 1 antagonism (Gonzalez et al., 
2011; Mohammad et al., 2007; Tallarida, 1992).
 To further examine the potential analgesic effect 
of silymarin and ketamine coadministration (by dou-
blingthe ED50s of both drugs given to mice), additional 
experiments were conducted to measure the analgesic 
effect of the combination 15 min after the administra-
tion by the thermal and chemical methods (Acharya 
et al., 2011; Le Bars et al., 2001).Acetic acid-induced 
writhing test in the mice,Thistest was conducted em-
ploying (Koster, 1959) method. Mice were divided 
into 4 groups of 6 mice each. The first group served 
as control and was given 10ml/kg i.p normal saline 
to act as control group. Groups II, received ketamine 
at 4mg/kg i.p , group III received silymarin at 120 
mg/kg i.p and the group IV received ketamine 4mg/
kg and silymarin 120 mg/kg i.p concomitantly . 15 
minutes later, each mouse was injected with (0.06% 
acetic acid of 1ml per 100g i.p). The number of ab-
dominal constriction for each mouse was counted 30 
minutes after injection of acetic acid . Percentage in-
hibition of writhing was calculated using the formula. 
Inhibition % = Mean no of writhes (control) – mean 
no of writhes (test) / Mean no of writhes (control) × 
100.
Statistical Analysis 
Data are expressed as mean + SEM. Statistical 
analysis was done by using one way analysis of vari-
ance (ANOVA).P<0.05were considered significant.
RESULTS 
 Hot plate test
 The ED50s for silymarin - and ketamine induced 
analgesia in mice, as determined by the up and- down 
method, were 57.22 and 1.96 mg/kg, ip, respectively 
(Table 1). The silymarin-treated mice appeared to be 
slightly sedated. However, Combined administration 
of silymarin and ketamine at fixed ratio ( 50:50) of 
their individual ED50 values were 38.4 and 1.28 mg/
kg, ip, respectively(Table 2) whereas , Combined ad-
ministration of silymarin and ketamine at fixed ratio 
(1:1) of their individual ED50 values were 47.54 and 
1.63 mg/kg, ip, respectively (Table 3). Isobolographic 
analysis of these ED50s for both drugs (either alone 
or in combination) at fixed ration either 0.5:0.5 or 1:1 
revealed that combined administration of the drugs 
has antagonistic effect on the induction of analgesia 
in mice (Fig. 1). This antagonistic effect was indi-
cated by the location of the points representing the 
combined analgesic ED50s of silymarin and ketamine 
above the diagonal line that connect their isoeffective 
analgesic doses (ED50s) given alone (Fig. 1). Further, 
the calculated interaction index for analgesia at fixed 
ration either 0.5:0.5 or 1:1 was 1.32 and 1.63 respec-
tively indicating an antagonistic interactions between 
both drugs (an index of > 1indicates antagonism). The 
animals did not reach the point of tissue damage, so at 
the end of the experiments, we didn’t have to give an 
analgesic dose.
Acetic acid-induced writhing response in mice
 We found that ketamine and silymarin at 4 mg/
kg and 120mg/kg significantly reduced the writhing 
number as compared to mice treated with normal sa-
line (control),silymarin 120mg/kg and ketamine 4mg/
kg (Table 4 ) . The percentage of inhibition of writhing 
was 62.1, 63.6 and 84.8 in ketamine at 4mg/kg ,sily-
marin 120mg/kg and concomitant silymarin 120mg/
kg +ketamine 4mg/kg treated mice, respectively (Ta-
ble 4 ) (Fig 1).
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Table 1. Median effective doses (ED50) of silymarin and ketamine administered ip alone for induction of analgesia in the hot plate 
test in mice
Variable Silymarin Ketamine 
ED50 57.22 1.96
Range of the doses used 100-40= 60mg/kg 2-1.5=0.5mg/kg
Initial dose 100mg/kg 2mg/kg
Last dose 40mg/kg 2mg/kg
Number of mice used 6(xxoxxo) 5(xoxoo)
Increase or decrease in the dose 20mg/kg 0.5mg/kg
aX – analgesia; O – no analgesia. The ED50s were determined by the up-and-down method (Dixon, 1980)
Table 2. Median effective doses (ED50) of silymarin and ketamine administered ip concomitantly for induction of analgesia in the hot 
plate test in mice at fixed ratio (0.5:0.5)
Variable Silymarin + Ketamine 
ED50 38.4mg/kg 1.28mg/kg
Range of the doses used 45-30= 15mg/kg 1.5-1=0.5mg/kg
Initial dose 30mg/kg 1mg/kg
Last dose 45mg/kg 1.5mg/kg
Number of mice used 5(oxoox)
Increase or decrease in the dose 7.5mg/kg 0.25mg/kg
Y 1.32
Table 3. Median effective doses (ED50) of silymarin and ketamine administered ip concomitantly for induction of analgesia in the hot 
plate test in mice at fixed ratio (1:1)
Variable Silymarin + Ketamine 
ED50 47.54mg/kg 1.58mg/kg
Range of the doses used 60-30= 30mg/kg 2-1=1 mg/kg
Initial dose 60mg/kg 2mg/kg
Last dose 45mg/kg 1.5mg/kg
Number of mice used 6(xxooxo)


















Figure 1. Isobolographic analysis of the analgesic interaction of silymarin and ketamine in mice.silymarin and ketamine was injected 
intraperitoneally. Points on x- and y-axes represent median analgesic doses (ED50s, mg/kg) of the drugs given alone, whereas the 
triangular point represents 1:1 of ED50 combinations of both drugs. The diagonal line between the individual ED50s of silymarin and 
ketamine is antagonistic and the triangular point indicates synergistic interaction.
n=5–6 mice/each ED50 experiment.
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Table 4. The analgesic activity of Silymarin and ketamine in visceral pain model-writhing method following concurrent administration 
in mice 
Groups Onset of writhing Numbers of writhing Percentage of 
inhibition 
Normal saline 31.5±3.7 13.2±1.7 0
Ketamine 4mg/kg 30.0±3.7 5.0±0.5* 62.1%
Silymarin 120mg/kg 37.5±3.7 4.8±0.5* 63.6%
Ketamine 4mg/kg+ Silymarin 120mg/kg 25.8±4.7 2.0±0.5*ab 84.8%
n = 6 for each group.The observations are mean ± SEM. 
* p<0.05, as compared to control 
a p<0.05, as compared to ketamine 4mg/kg .

















Figure 2. Isobolographic analysis of the analgesic interaction of silymarin and ketamine in mice . silymarin and ketamine was injected 
intraperitoneally. Points on x- and y-axes represent median analgesic doses (ED50s, mg/kg) of the drugs given alone, whereas the 
triangular point represents 0.5:0.5 of ED50 combinations of both drugs. The diagonal line between the individual ED50s of silymarin 
and ketamine is antagonistic and the triangular point indicates synergistic interaction.






















Figure 3. The analgesic activity of Silymarin and ketamine in visceral pain model-writhing method following concurrent administra-
tion in mice treated with normal saline , ketamine 4mg , silymarin 120mg and ketamine 4mg+ silymarin 120mg   were injected i.v. 30 
min before 0.6% acetic acid i.p. After 15 min the no. of abdominal constrictions was counted during 30 min. Results expressed as mean 
S.E.M. n=6for each group.
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DISCUSSION 
A large number of herbal medicinal products are 
reputed to have excellent medicinal value and are used 
to treat multiple ailments. In herbal medicine, differ-
ent indigenous drugs are used with considerable suc-
cess in single and/or combined forms to treat different 
types of inflammatory and arthritic illnesses(Hussain, 
Jassim, Numan, Al-Khalifa, & Abdullah, 2009). Sily-
marin produced considerable analgesic effects (on the 
writhing test) in mice either alone or in combination 
with ketamine while the combination of silymarin 
and ketamine was antagonistic in the hot plate test. 
Silymarin’s individual action is reliable with the re-
ported analgesic effect of the drug on mice, rats and 
chicks(Amin & Arbid, 2015; Hassani et al., 2015; G. 
B. Jadhav, Upasani, & others, 2009; Sahib, 2011)
 In the acetic acid induced writhing tests, the ad-
ministration of silymarin and ketamine combinations 
produced antinociceptive effects that were greater 
than would be achieved for individual drug adminis-
tration alone. 
The method of hot plate and tail immersion origi-
nally described by (Woolfe & Macdonald, 1944) was 
found to be suitable for the evaluation of analgesics 
that act centrally but not peripherally. Acetic acid in-
duced writhing is a sensitive approach for the testing 
of compounds ‘ peripheral analgesic effect. Peritoneal 
nociceptor stimulation is indirect and occurs by re-
leasing endogenous substances that stimulate nerve 
endings (Bhutia, Vijayaraghavan, & Pathak, 2010; 
Gawade, 2012). silymarin has cardioprotective, neu-
roprotective, cytoprotective, anti-inflammatoryan-
danti-carcinogenic effects, analgesic effect and hepa-
toprotective effects(Corchete, 2008; Fanoudi, Alavi, 
Karimi, & Hosseinzadeh, 2018; Kren & Walterová, 
2005; Semalty, Semalty, Rawat, & Franceschi, 2010) . 
Silymarin is a free radical scavenger that uses cycloo-
xygenase and lipoxygenase pathways to various steps 
in arachidonic acid cascade (O. P. Gupta et al., 2000).
Silymarin showed inhibitory effects on macrophage 
production of IL‐1β and PGE2 and blocked IL‐1β and 
cyclooxygenase‐2 expression of mRNA in LPS‐stim-
ulated RAW 264.7 cells (Mateen, Raina, & Agarwal, 
2013). There is a marked increase in the concentration 
of PGE2 and PGF2a in the peritoneal fluid following 
injection of acetic acid(Ricciotti, E., & FitzGerald, 
2011), and the analgesic effect of silymarin  similar to 
aspirin may be due to the Inhibition  of prostaglandin 
synthesis (Fiebrich & Koch, 1979; Soon, Young, 
Song-Kyu, Kyu-Hwan, & Mook, 2004).
Ketamine acts to induce analgesia and anesthe-
sia in humans and animals by antagonizing N-meth-
yl-D-aspartate receptors(Aiello & Mays, 1998; 
Cornick-Seahorn JL:, 2001; Rang et al., 2003) By 
interacting with the supraspinal μ-opioid receptors, 
ketamine also induces analgesia(Nieuwenhuijs et al., 
2004)In this context, by modulating phosphorylation 
in cells that express μ-opioid receptors endogenously, 
ketamine enhances opioid-induced analgesic signal-
ing(Gupta, A., Devi, L. A., & Gomes, 2011).
This is the first study to provide an isobolograph-
ic analysis of the analgesic interaction between sily-
marin and ketamine. These data suggest that silymarin 
and ketamine in combination may have greater than 
additive effects in the treatment of visceral hyperal-
gesic conditions.
In the present study, the analgesic effect of com-
bined administration of silymarin and ketamine was 
found to be antagonistic in the hotplate test as substan-
tiated by the isobolographic analysis of the individual 
and combined ED50s of both drugs for the induction 
of analgesia at a fixed ratio of 0.5:0.5 and 1:1 of their 
individual ED50s, resulting in an interaction index of 
>1 (1.32 and 1.63) respectively .The antagonistic ef-
fect at level of central nociception may be due to the 
different mechanism between two drug and may be 
due to the distribution of silymarin in the CNS.Most 
flavonoids are metabolized in the gastro-intestinal 
tract and liver, are absorbed into the bloodstream and 
can reach the CNS by crossing the blood brain barrier 
(BBB)(Rodriguez-Mateos et al., 2014). To date, there 
is little data on the bioavailability of flavonoids and 
their capacity to reach the CNS.Detection of certain 
polyphenols and their metabolites indifferent brain 
regions after oral administration of polyphenolic ex-
tracts in murine models indicates that at least some 
flavonoids are able to cross the BBB(El Mohsen et al., 
2002; Ferruzzi et al., 2009).
The pain eliciting models used in this study vary 
from one another and reflect the central (hot plate 
test) and peripheral (writhing test) mechanisms in-
volved in pain generation and recognition(Acharya 
et al., 2011; Dambisya YM, 1994; de Campos Buzzi 
F, Fracasso M, Filho VC & del Olmo E, 2010). Dif-
ferent research groups have used acetic acid induced 
writhing test primarily to evaluate antinociceptive of 
natural compounds worldwide(Danion, Diemunsch, 
& Brandt, 2000; V. K. Gupta, 2006). Several endoge-
nous noxious mediators such as bradykinin, serotonin, 
histamine, substance P(Danion et al., 2000; Irifune et 
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al., 1998) were released by acetic acid. The resulting 
pain is symbolized by abdominal muscle contraction 
accompanied by forelimb extension and elongation 
of the body. Our study did not investigate the mech-
anisms involved in the synergy between silymarin 
andketamine. The synergy observed with the writh-
ing test may be associated with a pharmacokinetic or 
pharmacodynamic interaction. Silymarin may induce 
a decrease in the glomerular excretion of ketamine 
and its active metabolite (i.e., norketamine) through 
prostaglandin synthesis inhibition..
A pharmacodynamic interaction is more likely, as 
indicated by the peak amplitude synergistic effect. 
Silymarin acts as analgesic primarily through periph-
eral inhibition of the cyclooxygenase enzyme (Hus-
sain et al. 2009). . Ketamine has mainly a central site 
of action through the block of NMDA receptors . A 
sensible hypothesis to explain our outcomes may be 
that silymarin decreased nociceptive inputs reaching 
the central nervous system, thereby improving the 
effectiveness of ketamine’s central action. A reduced 
frequency of nociceptive inputs is probable to require 
less blockage of the NMDA receptor to induce an 
analgesic effect.however, some researcher indicate 
that repeated administration of silymarin prevents the 
formalin – induced pain behavior but it is ineffective 
in the treatment of sciatic neuropathic pain in mice 
(Hassani et al., 2015) . Another proposed mechanism 
involves pharmacodynamic interactions between the 
two drug-affected receptors (Yaksh, 1994)However, 
in the present study, the combination of silymarin and 
ketamine not only induced synergistic antinociceptive 
effects, but also reduced side effects by reducing each 
drug’s dose. 
In conclusionsilymarin and ketamine have antag-
onistic antinociceptive effects at the central pain, but 
both drugs have synergeticantinociceptive effects at 
the peripheral pain .These results could be of clinical 
importance in the species of rodents or could be ex-
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